Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

iNNOVATE trial of added ibrutinib for Waldenströms Macroglobulinemia

Dr Meletios Dimopoulos - National and Kapodistrian University of Athens School of Medicine, Athens, Greece
iNNOVATE trial of added ibrutinib for Waldenströms Macroglobulinemia ( Dr Meletios Dimopoulos - National and Kapodistrian University of Athens School of Medicine, Athens, Greece )
16 Jun 2018

EHA 2018: Initial results of the INSIGHT trial in multiple myeloma

Prof Efstathios Kastritis and Dr Zhengzheng Fu
EHA 2018: Initial results of the INSIGHT trial in multiple myeloma ( Prof Efstathios Kastritis and Dr Zhengzheng Fu )
16 Jun 2018

EHA Topics in focus : Immunotherapy

Prof John Gribben - Barts Cancer Institute, London, United Kingdom
EHA Topics in focus : Immunotherapy ( Prof John Gribben - Barts Cancer Institute, London, United Kingdom )
16 Jun 2018

EHA 2018: The unmet needs in maintenance therapy for multiple myeloma

Prof Meletios Dimopoulos, Dr Shaji Kumar, Prof Meral Beksaç and Prof Wee Joo Chng
EHA 2018: The unmet needs in maintenance therapy for multiple myeloma ( Prof Meletios Dimopoulos, Dr Shaji Kumar, Prof Meral Beksaç and Prof Wee Joo Chng )
15 Jun 2018

EHA 2018: Results of the OPTIMISMM trial

Prof Paul Richardson - Dana-Farber Cancer Institute, Boston, USA
EHA 2018: Results of the OPTIMISMM trial ( Prof Paul Richardson - Dana-Farber Cancer Institute, Boston, USA )
15 Jun 2018

First results of DREAM trial of frontline durvalumab for mesothelioma

Prof Anna Nowak - The University of Western Australia, Perth, Australia
First results of DREAM trial of frontline durvalumab for mesothelioma ( Prof Anna Nowak - The University of Western Australia, Perth, Australia )
5 Jun 2018

International cancer control plans

Dr Verna Vanderpuye - Korle Bu Teaching Hospital, Accra, Ghana
International cancer control plans ( Dr Verna Vanderpuye - Korle Bu Teaching Hospital, Accra, Ghana )
4 Jun 2018

Updates in melanoma from ASCO 2018

Dr Alexander van Akkooi - Netherlands Cancer Institute, Amsterdam, Netherlands
Updates in melanoma from ASCO 2018 ( Dr Alexander van Akkooi - Netherlands Cancer Institute, Amsterdam, Netherlands )
4 Jun 2018

Finding appropriate doses for HER2 positive breast cancers

Dr Mariana Chavez-MacGregor - MD Anderson Cancer Center, Houston, USA
Finding appropriate doses for HER2 positive breast cancers ( Dr Mariana Chavez-MacGregor - MD Anderson Cancer Center, Houston, USA )
3 Jun 2018

Education, collaboration and communication in global cancer control

Dr Susannah Stanway - Royal Marsden NHS Foundation Trust, London, UK
Education, collaboration and communication in global cancer control ( Dr Susannah Stanway - Royal Marsden NHS Foundation Trust, London, UK )
3 Jun 2018

New pathways in pancreatic cancer

Dr Federico Sanchez - Aurora Sheboygan Memorial Medical Center, Sheboygan, USA
New pathways in pancreatic cancer ( Dr Federico Sanchez - Aurora Sheboygan Memorial Medical Center, Sheboygan, USA )
3 Jun 2018

Zoptarelin no better than doxarubicin for second-line advanced endometrial cancer

Dr David Miller - The University of Texas Southwestern Medical Center
Zoptarelin no better than doxarubicin for second-line advanced endometrial cancer ( Dr David Miller - The University of Texas Southwestern Medical Center )
2 Jun 2018